Nephrology Forum

Kidney International (1979) 16, 75–85; doi:10.1038/ki.1979.104

Relapsing nephrotic syndrome in childhood

Presentation of the Forum is made possible by grants from Hoechst-Roussel Pharmaceuticals Inc., Smith Kline & French Laboratories, G. D. Searle & Co., Warner-Lambert Pharmaceuticals Division, Burroughs Wellcome Company, Geigy Pharmaceuticals Inc., and Boehringer Ingelheim Ltd.

Principal Discussant: Warren E Grupe1

1Harvard Medical School and Children's Hospital Medical Center, Boston, Massachusetts

Correspondence: Dr Warren E Grupe, Division of Nephrology, Children's Hospital Medical Center, 300 Longwood Avenue, Boston, Massachusetts 02115.

Top

References

  1. Churg J, Habib R, White RHR: Pathology of the nephrotic syndrome in children. A report for the International Study of Kidney Disease in Children. Lancet 1:1299, 1970 | ISI |
  2. White RHR, Glasgow EF, Mills RJ: Clinicopathological study of nephrotic syndrome in childhood. Lancet 1:1353, 1970 | PubMed | ISI | ChemPort |
  3. Habib R, Kleinknecht C: The primary nephrotic syndrome of childhood: Classification and clinicopathologic study of 406 cases, in Pathology Annual, edited by Summers SC, New York, Appleton-Century-Crofts, 1971, p. 417
  4. International Study of Kidney Disease in Children. Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13:159, 1978
  5. Sharpstone P, Ogg CS, Cameron JS: Nephrotic syndrome due to primary renal disease in adults. I. Survey of incidence in Southwest England. Br Med J 2:533, 1969
  6. Schlesinger ER, Sultz HA, Mosher WE, Feldman JG: The nephrotic syndrome. Its incidence and implications for the community. Am J Dis Child 116:623, 1968 | PubMed | ISI | ChemPort |
  7. Makker SP, Heymann W: The idiopathic nephrotic syndrome of childhood: a clinical re-evaluation of 145 cases. Am J Dis Child 127:830, 1974 | ChemPort |
  8. Munk F: Die Nephrosen. Med Klin 12:1019, 1916
  9. Barnett HL, Forman CW, Lauson HD: The nephrotic syndrome in children, in Advances in Pediatrics edited by Levine SA, Chicago, Yearbook Medical Publishers, Inc, 1952, Vol. 5, p. 53
  10. Grupe WE: Primary nephrotic syndrome in childhood, in Advances in Pediatrics edited by Barness LA, Chicago, Year Book Medical Publishers, Inc, 1980 (in press)
  11. Cameron JS: Histology, protein clearances and response to treatment in nephrotic syndrome. Br Med J 4:352, 1968
  12. White RHR: The nephrotic syndrome, in Recent Advances in Pediatrics, Edition 4, edited by Gairdner D and Hull D, London, J. & A. Churchill, 1971, p. 281
  13. Mallick NP: The pathogenesis of minimal change nephropathy. Clin Nephrol 7:87, 1977
  14. Gerber MA, Paronetto F: IgE in glomeruli of patients with nephrotic syndrome. Lancet 1:1097, 1971 | PubMed | ISI | ChemPort |
  15. Giangiacomo J, Cleary TG, Cole BR: Serum immunoglobulins in the nephrotic syndrome: A possible cause of minimal change nephrotic syndrome. N Engl J Med 293:8, 1975 | PubMed | ISI | ChemPort |
  16. Ingelfinger JR, Link DA, Davis AE, Grupe WE: Serum immunoglobulins in idiopathic minimal-change nephrotic syndrome. N Engl J Med 294:50, 1976
  17. Lange K, Craig F, Oberman J, Slobody L, Ogur G, Locasto F: Changes in serum complement during the course and treatment of glomerulonephritis. Arch Intern Med 88:433, 1951
  18. Ngu JL, Barratt TM, Soothill JF: Immunoconglutinin and complement changes in steroid sensitive relapsing nephrotic syndrome of children. Clin Exp Immunol 6:109, 1970
  19. Levinsky RJ, Malleson PH, Barratt TM, Soothill JF: Circulating immune complexes in steroid responsive nephrotic syndrome. N Engl J Med 298:126, 1978
  20. O'Regan S, Smith M, Drummond KN: Immune complex infusion in the rat. Renal functional and morphologic changes. Clin Exp Immunol 24:110, 1976
  21. Lagrue G, Branellec A, Blanc C: A vascular permeability factor in lymphocyte culture supernatants from patients with nephrotic syndrome; II, pharmacological and physiochemical properties. Biomedicine 23:73, 1975 | PubMed |
  22. Eyres KE, Mallick NP, Taylor G: Evidence for cell mediated immunity to renal antigens in minimal change nephrotic syndrome. Lancet 1:1158, 1976
  23. Mallick NP, Williams RJ, McFarlane H, Taylor G, Williams G: Cell mediated immunity in nephrotic syndrome. Lancet 1:507, 1972 | PubMed | ISI |
  24. Ooi BS, Orlina AR, Masaitis L: Lymphocytotoxins in primary renal disease. Lancet 2:1348, 1974
  25. Moorthy AV, Zimmermann SW, Burkholder PM: Inhibition of lymphocyte blastogenesis by plasma of patients with minimal change nephrotic syndrome. Lancet 1:1160, 1976 | PubMed | ISI | ChemPort |
  26. Shalhoub RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2:556, 1974 | PubMed | ISI | ChemPort |
  27. Cameron JS, Turner DR, Ogg CS: The nephrotic syndrome in adults with minimal change glomerular lesions. O J Med 171:461, 1974
  28. Arneil GC: The nephrotic syndrome. Pediatr Clin N Amer 18:547, 1971
  29. Arneil GC: One hundred and sixty-four children with nephrosis. Lancet 2:1103, 1961
  30. Cornfeld D, Schwartz MW: Nephrosis: A long term study of children treated with corticosteroids. J Pediatr 68:507, 1966
  31. Arneil GC, Lam CN: Long term assessment of steroid therapy in childhood nephrosis. Lancet 2:819, 1966
  32. Siegel NJ, Goldberg B, Krassner LS, Hayslett JP: Long-term follow-up of children with steroid-responsive nephrotic syndrome. J Pediatr 81:251, 1972
  33. Schwartz MW, Schwartz GJ, Cornfeld D: A 16 year follow-up study of 163 children with nephrotic syndrome. Pediatrics 54:547, 1974
  34. White RHR: Cytotoxic drug therapy in steroid-resistant glomerulonephritis. Proc Roy Soc Med 60:1164, 1967
  35. McCrory WW, Shibuya M, Lu WH, Lewy JE: Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome. J Pediatr 82:614, 1973 | PubMed | ISI | ChemPort |
  36. Grupe WE, Heymann W: Cytotoxic drugs in steroid-resistant renal disease. Am J Dis Child 112:448, 1966 | PubMed | ISI | ChemPort |
  37. White RHR, Cameron JS, Trounce JR: Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Br Med J 2:853, 1966 | PubMed |
  38. Michael AF, Vernier RL, Drummond KN: Immunosuppressive therapy of chronic renal disease. N Engl J Med 273:943, 1967
  39. Abramowicz M, Barnett HL, Edelmann CM: Controlled trial of azathioprine in children with nephrotic syndrome. Lancet 1:959, 1970 | PubMed | ISI | ChemPort |
  40. International Study of Kidney Disease in Children: Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 2:423, 1974
  41. Rance CP, Arbus GS, Balfe JW: Management of the nephrotic syndrome in children. Pediatr Clin N Amer 23:735, 1976
  42. Grupe WE, Makker SP, Ingelfinger JR: Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 295:746, 1976 | PubMed | ISI | ChemPort |
  43. Williams SA, Makker SP, Ingelfinger JR, Grupe WE: Long-term evaluation of chlorambucil, including effects of dose, in idiopathic nephrotic syndrome of childhood Pediatr Res 11:560, 1977
  44. Baluarte HJ, Hiner L, Gruskin AB: Chlorambucil dosage in frequently relapsing nephrotic syndromie. A controlled clinical trial. J Pediatr 92:295, 1978 | PubMed | ISI | ChemPort |
  45. Miller JJ, Williams GF, Leissring JC: Multiple late complications of therapy with cyclophosphamide, including ovarian dysfunction. Am J Med 50:530, 1971 | Article | PubMed | ISI |
  46. Etteldorf JN, West CD, Pitcock JA, Williams DL: Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr 88:206, 1976
  47. Richter P, Calamera JC, Morgenfeld MC, Kierszenbaum AL, Lavieri JC, Mancini RF: Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma. Cancer 25:1026, 1970
  48. Guesry P, Lenoir G, Broyer M: Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr 92:299, 1978
  49. Buchanan JD, Fairley KF, Barrie JV: Return of spermatogenesis after stopping cyclophosphamide therapy. Lancet 2:156, 1975
  50. Cheviakoff S, Calamera JC, Morgenfeld M, Mancini RE: Recovery of spermatogenesis in patients with lymphoma after treatment with chlorambucil. J Reprod Fert 33:155, 1973
  51. Cameron S: Chlorambucil and leukemia. N Engl J Med 296:1065, 1977 | PubMed | ISI | ChemPort |
  52. Westberg NG, Swolin B: Acute myeloid leukemia appearing in two patients after prolonged continuous chlorambucil treatment for Wegener's granulomatosis. Acta Med Scand 199:373, 1976
  53. Williams SA, Makker SP, Grupe WE: Seizures: Clinical significant side effect of chlorambucil therapy in children. J Pediatr 93:516, 1978
  54. Brodehl J, Krohn HP: Steroid trial in frequently relapsing nephrotic syndrome in children, in Glomerulonephritis. International Conference on Pathogenesis, Pathology and Treatment edited by Kluthe R, Vogt A, Batsford SR, Stuttgart, George Thieme Publishers, 1976, p. 210
  55. Leisti S, Vilska J, Hallman N: Adrenocortical insufficiency and relapsing in idiopathic nephrotic syndrome in childhood. Pediatrics 60:334, 1977
  56. Leisti S, Koskimies O, Rapola J: Association of post-medication hypocortisolism with early relapse of idiopathic nephrotic syndrome. Lancet 2:795, 1977 | PubMed |
  57. Soyka LF, Saxena KM: Alternate-day steroid therapy for nephrotic children. JAMA 192:225, 1965
  58. Soyka LF: Treatment of the nephrotic syndrome in childhood. Use of an alternate-day prednisone regimen. Am J Dis Child 113:693, 1967
  59. vanAcker KJ, Hooft C: The influence of hormone treatment on the natural evolution of the idiopathic nephrotic syndrome in childhood. Acta Paediatr Scand 57:479, 1968
  60. McLean RH: Personal communication, 1978
  61. Seiler MW, Rennke HG, Venkatachalam MA: Pathogenesis of polycation induced alterations ("fusion") of glomerular epithelium. Lab Invest 36:48, 1977 | PubMed | ISI | ChemPort |
  62. Root ER, Conley SB, Robson AM: Effect of glomerular polyanion removal on proteinuria. Pediatr Res 11:555, 1977
  63. Schneeberger EE, Grupe WE: The ultrastructure of the glomerular slit diaphragm in autologous immune complex nephritis. Lab Invest 34:298, 1976 | PubMed |
  64. Schneeberger EE, O'Brien MA, Grupe WE: Altered glomerular permeability in Munich-Wistar rats with autologous immune complex nephritis. Lab Invest 40:227, 1979
  65. Rennke HG, Couser WG, Patel Y, Venkatachalam MA: Membranous nephropathy. Fractional clearances of anionic, neutral and cationic horseradish peroxidase in Lewis rats with autologous immune complex nephritis. Abstr Int Congr Nephrol, Montreal, 1978, p. X2
  66. Kanwar YS, Farquhar MG: Characterization of anionic sites in the glomerular basement membrane (GBM). Kidney Int 14:713, 1978
  67. Blau EB, Haas DE: Glomerular sialic acid and proteinuria in human renal disease. Lab Invest 28:477, 1973
  68. Jao W, Pollack VE, Norris VE: Lipoid nephrosis: an approach to the clinicopathologic analysis and dismemberment of idiopathic nephrotic syndrome with minimal glomerular changes. Medicine 52:445, 1973

Extra navigation

.
ADVERTISEMENT